Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis
NCT ID: NCT00862654
Last Updated: 2021-02-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
326 participants
INTERVENTIONAL
2009-03-31
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis
NCT00400725
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
NCT01111981
The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis
NCT02448082
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
NCT01309191
Evaluation of the Efficacy of SeS2 Shampoo on Subjects Having Dandruff
NCT05506592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
C propionate 4/week + Ketoconasole 2/week
Clobetasol propionate shampoo 0.05% (4/week) + Ketoconazole shampoo 2% (2/week)
clobetasol propionate shampoo (4/week) - ketoconazole shampoo (2/week)
Association: clobetasol propionate shampoo \& ketoconazole shampoo
C propionate 2/week + Ketoconasole 2/week
Clobetasol propionate shampoo 0.05% (2/week) + Ketoconazole shampoo 2% (2/week)
clobetasol propionate shampoo (2/week) - ketoconazole shampoo (2/week)
Association: clobetasol propionate shampoo \& ketoconazole shampoo
C propionate 2/week
Clobetasol propionate shampoo 0.05% (2/week)
clobetasol propionate shampoo (2/week)
Monotherapy with clobetasol propionate shampoo
Ketoconazole 2/week
Ketoconazole shampoo 2% (2/week)
ketoconazole shampoo (2/week)
Monotherpay ketoconazole shampoo (2/week)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
clobetasol propionate shampoo (4/week) - ketoconazole shampoo (2/week)
Association: clobetasol propionate shampoo \& ketoconazole shampoo
clobetasol propionate shampoo (2/week) - ketoconazole shampoo (2/week)
Association: clobetasol propionate shampoo \& ketoconazole shampoo
clobetasol propionate shampoo (2/week)
Monotherapy with clobetasol propionate shampoo
ketoconazole shampoo (2/week)
Monotherpay ketoconazole shampoo (2/week)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Subjects with a known allergy to one of the components of the test products,
* Female subjects who are pregnant, nursing or planning a pregnancy during the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Paul Ortonne, MD
Role: PRINCIPAL_INVESTIGATOR
Nice Hospital (France)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Galderma Investigational Center
Bruges, , Belgium
Galderma Investigational Center
Brussels, , Belgium
Galderma Investigational Center
Geel, , Belgium
Galderma Investigational Center
Ghent, , Belgium
Galderma Investigational Center
Liège, , Belgium
Galderma Investigational Center
Mons, , Belgium
Galderma Investigational Center
Paris, , France
Galderma Investigational Center
Berlin, , Germany
Galderma Investigational Center
Bonn, , Germany
Galderma Investigational Center
Hamburg, , Germany
Galderma Investigational Center
Lübeck, , Germany
Galderma Investigational Center
Mahlow, , Germany
Galderma Investigational Center
Wuppertal, , Germany
Galderma Investigational Center
Guadalajara, , Mexico
Galderma Investigational Center
México, , Mexico
Galderma Investigational Center
Naucalpan, , Mexico
Galderma Investigational Center
Zapopan, Jalisco, , Mexico
Galderma Investigational Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ortonne JP, Nikkels AF, Reich K, Ponce Olivera RM, Lee JH, Kerrouche N, Sidou F, Faergemann J. Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study. Br J Dermatol. 2011 Jul;165(1):171-6. doi: 10.1111/j.1365-2133.2011.10269.x.
Related Links
Access external resources that provide additional context or updates about the study.
Sponsor general information
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD.03.SPR.29079
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.